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CIN85 regulates dopamine receptor endocytosis and governs
behaviour in mice
Abstract
Despite extensive investigations of Cbl-interacting protein of 85 kDa (CIN85) in receptor trafficking
and cytoskeletal dynamics, little is known about its functions in vivo. Here, we report the study of a
mouse deficient of the two CIN85 isoforms expressed in the central nervous system, exposing a function
of CIN85 in dopamine receptor endocytosis. Mice lacking CIN85 exon 2 (CIN85(Deltaex2)) show
hyperactivity phenotypes, characterized by increased physical activity and exploratory behaviour.
Interestingly, CIN85(Deltaex2) animals display abnormally high levels of dopamine and D2 dopamine
receptors (D2DRs) in the striatum, an important centre for the coordination of animal behaviour.
Importantly, CIN85 localizes to the post-synaptic compartment of striatal neurons in which it co-clusters
with D2DRs. Moreover, it interacts with endocytic regulators such as dynamin and endophilins in the
striatum. Absence of striatal CIN85 causes insufficient complex formation of endophilins with D2DRs
in the striatum and ultimately decreased D2DR endocytosis in striatal neurons in response to dopamine
stimulation. These findings indicate an important function of CIN85 in the regulation of dopamine
receptor functions and provide a molecular explanation for the hyperactive behaviour of
CIN85(Deltaex2) mice.
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Abstract 
Despite extensive investigations of CIN85 (Cbl-interacting protein of 85kDa) in receptor 
trafficking and cytoskeletal dynamics, little is known about its functions in vivo. Here we 
report the study of a mouse deficient of the two CIN85 isoforms expressed in the CNS, 
exposing a role of CIN85 in dopamine receptor endocytosis. Mice lacking CIN85 exon2 
(CIN85Δex2) show hyperactivity phenotypes, characterized by increased physical activity and 
exploratory behavior. Interestingly, CIN85Δex2 animals display abnormally high levels of 
dopamine and D2 dopamine receptors (D2DRs) in the striatum, an important centre for the 
coordination of animal behavior. Importantly, CIN85 localizes to the post-synaptic 
compartment of striatal neurons where it co-clusters with D2DRs. Moreover, it interacts with 
endocytic regulators such as dynamin and endophilins in the striatum. Absence of striatal 
CIN85 causes insufficient complex formation of endophilins with D2DRs in the striatum and 
ultimately decreased D2DR endocytosis in striatal neurons in response to dopamine 
stimulation. These findings indicate an important role of CIN85 in the regulation of dopamine 
receptor functions and provide a molecular explanation for the hyperactive behavior of 
CIN85Δex2 mice. 
 
Introduction 
CIN85 (Cbl-interacting protein of 85 kDa)/SH3KBP1 (SH3-domain kinase binding 
protein 1) forms, together with CMS (p130Cas ligand with multiple SH3 domains)/CD2AP 
(CD2-associated protein), a family of adaptor molecules with established roles in 
coordinating the spatial and temporal assembly of protein complexes during receptor 
endocytosis, formation of kidney glomeruli and organization of the immunological synapse in 
T cells (Dikic, 2002). Common to both CIN85/SH3KBP1 (alias CIN85) and CMS/CD2AP is 
a core structural organization comprising three N-terminal SH3 domains, followed by a 
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centrally located proline-rich region and a C-terminal coiled-coil (Dikic, 2002). Also in a 
functional perspective both family members share certain characteristics, given that their SH3 
domains specifically recognize a consensus Px(P/A)xxR motif, present in Cbl (Jozic et al., 
2005; Kobayashi et al., 2004; Kurakin et al., 2003; Moncalian et al., 2006; Petrelli et al., 
2002; Soubeyran et al., 2002) and other proteins involved in endocytosis, including 
synaptojanin, Huntington interacting protein 1 related (HIP1R), Alix and Dab2 (Chen et al., 
2000; Kowanetz et al., 2004), as well as regulators of the actin cytoskeleton, such as cortactin 
and the actin capping protein CAPZ (Cormont et al., 2003; Hutchings et al., 2003; Kirsch et 
al., 2001; Lynch et al., 2003; Welsch et al., 2001). Indeed, a role of CIN85 and CMS/CD2AP 
in the regulation of actin dynamics is emphasized by their ability to directly interact with F-
actin and induce bundling of actin filaments (Gaidos et al., 2007). The multitude of verified 
interaction partners has placed CIN85 as a central adaptor molecule involved in the 
recruitment of the endocytic machinery required for the internalization of a variety of cell 
surface receptors, including growth factor receptors (such as EGFR, Met and VEGFR) 
(Kobayashi et al., 2004; Petrelli et al., 2002; Soubeyran et al., 2002), immunoglobulin IgE 
receptors in mast cells (Molfetta et al., 2005), as well as during the infectious internalization 
of the bacterial pathogen Listeria monocytogenes (Veiga and Cossart, 2005).  
Despite sharing many overlapping molecular functions in cultured cells, 
investigations in mice deficient of CD2AP have highlighted that CIN85 and CD2AP may 
have distinct functions in vivo. In agreement with its abundance in the kidney, mice lacking 
CD2AP suffer from a nephrotic syndrome caused by defective podocyte functionality during 
the formation of the glomerular slit diaphragm, eventually resulting in lethality at 6-8 weeks 
of age (Shih et al., 1999). An important role for CD2AP in spermatocyte production has 
furthermore been established, given that podocyte-specific reintroduction of transgenic 
CD2AP in knockout mice is sufficient to rescue animals into adulthood, but renders male 
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mice infertile (Grunkemeyer et al., 2005). Interestingly, the podocyte and the cells of the 
basal seminiferous tubule are both cell types in which CIN85 is poorly expressed. 
As a result of alternative splicing and differential promoter utilization, the mouse 
CIN85 genomic locus gives rise to multiple isoforms, including CIN85-xl, CIN85-l (CIN85), 
CIN85-ΔA, CIN85-m, CIN85-s, CIN85-t and CIN85-h (Figure S1) (Buchman et al., 2002; 
Finniss et al., 2004). The different isoforms display specific patterns of expression, among 
which CIN85-xl and CIN85-l are most abundant in brain and CIN85-l and CIN85-ΔA in 
thymus and spleen (Figure 2D, Figure S1 and (Buchman et al., 2002)). Lower levels of 
various isoforms can also be detected in kidney, muscle, skin, heart, lung and testis 
((Buchman et al., 2002) and unpublished observations). CD2AP is on the other hand 
predominantly expressed in spleen, thymus, heart, kidney, lung, muscle and liver, but appears 
to be lacking in neuronal cells (Dustin et al., 1998; Li et al., 2000; Shih et al., 1999). 
In this study, we report a novel role of CIN85 in the regulation of post-synaptic 
dopamine receptor endocytosis in striatal neurons. In wild-type mice, CIN85 resides post-
synaptically and associates with endocytic regulators, such as dynamin and endophilins. In 
mouse striatal neurons, absence of brain-specific CIN85 expression results in inefficient 
complex formation between dopamine receptors and endophilins, as well as reduced 
internalization of stimulated dopamine receptors. Mice deficient of brain-specific CIN85 
expression show hyperactive phenotypes, which in many ways resemble the behavioral 
aberrations displayed in humans affected by attention deficit hyperactivity disorder (ADHD), 
a disorder strongly associated with abnormal dopamine signaling. 
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Results 
Specific isoforms of CIN85 localize post-synaptically in neurons 
Since CIN85 is highly expressed in the brain (Buchman et al., 2002) we were interested to 
investigate the function of CIN85 in the central nervous system (CNS). We initially analyzed 
the expression pattern of CIN85 in various brain regions prepared from both mouse and rat 
(Figure 1A, Figure S2 and data not shown) and found both of the major isoforms expressed 
in brain, CIN85-xl and CIN85-l, to be abundant in most brain regions tested, in line with 
previously reported observations (Bian et al., 2008). In order to refine our survey of CIN85 
localization on a sub-cellular level, we subsequently performed immunohistochemical 
analysis of endogenous CIN85 in cultured primary rat hippocampal neurons with mature 
synapses. In agreement with previously reported observations (Kawata et al., 2006) and as 
shown in Figure 1B, we found high levels of CIN85 in the somatodendritic compartment, 
where it frequently clustered in dendritic shafts, as well as within dendritic spines. Dendritic 
spines are small protrusions extending from the surface of dendrites which are believed to be 
the main sites of excitatory synapses and thus vital centers for synaptic transmission in the 
brain (Segal, 2005).  
We confirmed the localization of CIN85 in dendritic spines by demonstrating a co-
localization of CIN85 with F-actin, which is abundant in these structures (Figure 1B, upper 
panel). In addition, by counter-staining the primary hippocampal neurons for CIN85 together 
with markers for pre- (synaptophysin) and post- (PSD-95) synaptic compartments, we found 
CIN85 to co-localize with PSD-95 at post-synaptic sites, closely juxtaposing synaptophysin 
(Figure 1B, middle and lower panel, respectively). Also in cultured primary striatal 
neurons CIN85 was enriched in spine-like structures in dendrites (Figure 1C). Aiming at 
further characterizing the localization of CIN85 in neurons, we subsequently isolated 
synaptosomes, which are enriched in pre- and post-synaptic structures (Booth and Clark, 
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1978), from whole mouse brain preparations, as well as from isolated mouse striata, using 
conventional Percoll step-gradient or sucrose density gradient centrifugations, respectively. 
Whereas CIN85, PSD-95 and synaptophysin were all present in crude synaptosomal isolates 
from whole mouse brains, further extraction with Triton X-100, which is known to 
specifically solubilize pre-synaptic compartments and thus enrich post-synaptic components, 
depicted an enrichment of CIN85 together with PSD-95 in the post-synaptic fractions (Figure 
1D). Similar results were obtained in isolated mouse striata where CIN85 co-fractionated 
with PSD-95 in post-synaptic density preparations (Figure 1E). 
 
Mice lacking brain-specific CIN85 isoforms are hyperactive 
In order to investigate the role of CIN85 in the CNS we next set out to generate mice 
deficient of the two major CIN85 isoforms expressed in the brain (CIN85-xl and CIN85-l). 
Using homologous recombination we targeted exon 2 of the CIN85 genomic locus for 
deletion (Figure 2A) and could by a combinatorial approach based on Southern Blot (Figure 
2B) and PCR (Figure 2C and Figure S3) confirm a successful integration of the targeting 
vector and absence of CIN85 exon 2. In agreement with the observed loss of CIN85 exon 2 
on the DNA level, we could furthermore confirm the absence of CIN85-xl and CIN85-l 
isoforms in brain, as well as CIN85-l in thymus and spleen, in CIN85Δex2 knockout mice by 
Western blot analysis (Figure 2D). As expected, whereas all CIN85 protein variants encoded 
by transcripts initiated from promoter #1 (CIN85-xl, CIN85-l and the shorter CIN85-ΔCP) 
were abolished in CIN85Δex2 mice, none of the transcripts utilizing alternative, downstream 
promoters, such as that of CIN85-ΔA (Figure 2D, Figure S1 and (Buchman et al., 2002)), 
were affected by the induced recombination event. Importantly, the neo-cassette, which as a 
result of the homologous recombination event replaces exon 2 in CIN85Δex2 animals, has been 
designed with a terminal translational stop codon, which should make ribosomal read-through 
 7
and re-initiation highly unlikely. Moreover, given that exon 1 and 3 have been placed out of 
frame in the targeting construct, we anticipate that splicing events skipping the introduced 
LacZ/neo-cassette should result in inappropriate and prematurely terminated translation. 
Homozygous CIN85Δex2 mice are viable and fertile, and display no obvious 
abnormalities. However, since neurological phenotypes may not be evident at first glance and 
often progress with age, we subjected the CIN85Δex2 knockouts to extensive analyses of a 
broad range of parameters according to the physiological screens defined by the German 
Mouse Clinic (GMC), summarized in Figure S4A and the Supplemental information. Among 
the parameters tested, the screen exposed a clear knockout-specific phenotype in energy 
metabolism, behavior (see below) and gene expression profiles (data not shown). When 
comparing CIN85Δex2 knockout and wild-type animals, we found that mice deficient of 
CIN85-xl and CIN85-l showed deviations in several metabolic parameters, including 
increased energy uptake, higher lean mass and lower fat content (Figure 3A and Figure 
S4B), characteristics that in many ways resemble the phenotypes previously reported for c-
Cbl knockout mice (Molero et al., 2004). 
In agreement with a role of CIN85 in the CNS, CIN85Δex2 mice also displayed obvious 
aberrations in behavior (Figure 3B). When subjected to the modified hole-board test, which 
assays spontaneous behavior such as forward and vertical locomotor activity, speed of 
movement and exploratory behavior in a novel environment (Figure S4C), CIN85Δex2 mice 
showed significantly increased activities, as compared to wild-type littermates (Figure 3B). 
Specifically, CIN85Δex2 animals exhibited enhanced forward locomotor activity, manifested 
by an increase in total distance traveled, number of line crossings, mean and maximum 
velocity, as well as turning frequency (Figure 3B and Figure S4C). In addition, CIN85Δex2 
knockout mice showed enhanced exploratory behavior - entering the board more frequently 
and exploring a larger number of holes on the board, than wild-type animals (Figure 3B). 
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Increase in total time spent on the board just missed a significant genotype effect limit (p = 
0.06, n.s.; Figure 3B). The increased physical activity displayed by the CIN85Δex2 animals 
should naturally be accompanied by an increased energy demand and indeed these mice show 
an increased energy intake (Figure 3A). However, given the lean body composition 
phenotype of these animals, the increased energy intake cannot completely compensate for 
the increased energy requirements. In summary, CIN85Δex2 mice are characterized by 
hyperactive behavior, as evidenced by the increased locomotor and exploratory activities. 
 
No obvious alterations in LTP, short-term synaptic plasticity, learning and memory in 
CIN85Δex2 knockout mice 
The similarity of the metabolic phenotypes displayed by CIN85Δex2 and c-Cbl knockout mice 
is interesting in light of a recent report indicating brain-specific activities of another member 
of the Cbl protein family, Cbl-b, which is involved in the regulation of long-term memory as 
well as short-term synaptic plasticity (Tan et al., 2006). This connection, together with the 
localization of CIN85 in dendritic spines of hippocampal neurons, led us to hypothesize that 
deficits in synaptic plasticity may be an underlying cause of the behavioral alterations 
observed in CIN85Δex2 mice. To address this question we implemented established 
electrophysiological stimulation protocols (Freudenthal et al., 2004) to study synaptic 
plasticity in CIN85Δex2 mutants in vivo. Initially we recorded field excitatory postsynaptic 
potentials (fEPSPs) in the dentate gyrus as a read-out of synaptic strength. In this assay, we 
found the synaptic response to be equally potentiated by tetanic stimulation in wild-type and 
CIN85Δex2 mice, thus indicating long-term potentiation (LTP) to be normal in the absence of 
CIN85 (Figure S5A). Importantly, the stimulus-response curves of fEPSP slopes and 
population spikes, depicting synaptic strength and granule cell firing, respectively, were also 
unaltered in the mutants (Figure S5B). Subsequently, we also analyzed presynaptic short-
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term plasticity and GABAergic network inhibition by performing paired-pulse stimulation 
tests. However, in none of these assays did CIN85Δex2 knockout mice show any significant 
differences as compared to wild-type animals (Figure S5C). We furthermore exposed the 
CIN85Δex2 mutants to learning and memory tests, and in line with the normal LTP and short-
term plasticity, CIN85Δex2 knockout mice showed normal spatial learning in a water-maze 
place navigation task (Figure S6A-C), as well normal associative and contextual memory in 
a fear conditioning task (Figure S6A, D, E). Taken together, absence of CIN85 in the CNS 
does not cause any obvious abnormalities in learning and memory. 
 
Dopamine receptor endocytosis is impaired in the absence of CIN85 
The genetics behind behavioral traits such as locomotor activity and exploratory ambition is 
undoubtedly highly complex and involves a multitude of pathways, among which 
serotonergic, dopaminergic and noradrenergic signaling are frequently quoted (Pattij and 
Vanderschuren, 2008). Based on multiple studies reporting involvement of dopaminergic 
signaling in the regulation of movement, learning, reward-seeking behavior and motivation 
(Yao et al., 2008), together with the rich clustering of dopamine receptors in dentritic spines 
(Gainetdinov et al., 2004; Missale et al., 1998; Viggiano et al., 2004; Yao et al., 2008; Zhu et 
al., 2004), we next investigated whether CIN85 could be involved in the regulation of 
dopamine signaling.  
Based on the fact that increased levels of dopamine in the striatum have been 
correlated with locomotor hyperactivity phenotypes (Gainetdinov et al., 2004; Viggiano et al., 
2004; Zhu et al., 2004) we first set out to analyze dopamine levels in the striatum of 
CIN85Δex2 knockout mice, using HPLC electro-chemical detection. Interestingly, we found 
that CIN85Δex2 knockout animals displayed significantly increased levels of dopamine in the 
striatum compared to wild-type animals (approximately 65% increase, Student’s t-test, p < 
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0.05) (Figure 4A). Since elevation of dopamine levels should convey accumulation also of 
its metabolites, we additionally quantified the striatal concentrations of the dopamine 
metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). In the 
process of dopamine degradation, dopamine is first converted into DOPAC and finally, after 
a series of subsequent events, into HVA, the end product in the dopamine metabolic pathway. 
The amounts of striatal DOPAC and HVA were higher in CIN85Δex2 knockout mice 
compared to wild-type littermates, consistent with the observed increase in dopamine levels 
(Figure 4A). Augmentation of dopamine levels may have multiple explanations, but in light 
of previous studies reporting important functions for CIN85 in the endocytic regulation of 
multiple cell surface receptors (see introduction and (Kobayashi et al., 2004; Molfetta et al., 
2005; Petrelli et al., 2002; Soubeyran et al., 2002; Veiga and Cossart, 2005)), we reasoned 
that the accumulation of dopamine in CIN85Δex2 mutant striata could be caused by defective 
internalization of dopamine receptors. Mammalian genomes have been reported to encode at 
least five different dopamine receptor sub-types, all belonging to the seven transmembrane G 
protein-coupled receptor superfamily (Yao et al., 2008). The receptors are entitled D1-D5 and 
fall into two distinct classes based on sequence and functional similarities, the D1-like (D1 
and D5) and D2-like (D2, D3, D4) dopamine receptors. Whereas D1-like receptors are highly 
expressed in the prefrontal cortex, D2-like receptors, in particular the D2 dopamine receptor 
(D2DR) (Gainetdinov et al., 2004; Missale et al., 1998), show stronger expression in the 
striatum and nucleus accumbens (Arias-Carrion and Poppel, 2007). Even though D1 
dopamine receptors (D1DRs) are also expressed in the striatum, D1 and D2 dopamine 
receptors are in general segregated into distinct striatal neurons. Neurons expressing both 
receptor types are rare (Missale et al., 1998). Given the intriguing expression pattern of 
dopamine receptors we were interested to analyze whether removal of CIN85-l and -xl 
isoforms in the striatum affects the endocytosis of D1 and/or D2 dopamine receptors. For this 
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purpose, we employed biotinylated D1DR and D2DR dopamine agonists to perform 
internalization assays in cultured primary striatal neurons from wild-type and CIN85Δex2 
knockout mice, allowing us to follow the uptake of either D1 or D2 dopamine receptors after 
dopamine stimulation. Interestingly, we detected diverging effects on the endocytosis of D1 
versus D2 dopamine receptors. When stimulating the neurons with dopamine for 5, 15, 30 
and 60 min, neurons derived from wild-type animals rapidly decreased the levels of D2 
dopamine receptors on the cell surface, whereas the levels of cell surface-associated D2DRs 
in neurons from CIN85Δex2 knockout mice remained high throughout the time course, 
depicting a role for CIN85 in D2DR internalization (Figure 4B). Specifically, after 15, 30 
and 60 min of stimulation, striatal neurons from CIN85Δex2 knockout mice still maintained 
high levels of surface D2DRs (96.5%, 87.5% and 78,1%, respectively), as compared to wild-
type neurons, which displayed significantly reduced levels (72.3%, 59.7% and 45,1%, 
respectively) (p<0.05) (Figure 4B). In contrast to D2DRs, internalization of D1 dopamine 
receptors occurred at comparable levels in striatal neurons from wild-type and CIN85Δex2 
knockout mice (Figure 4C). In both experiments, the level of an unrelated receptor 
(Glutamate receptor-2) was used as an internal control and did not change throughout the 
time course. To confirm the involvement of CIN85 in D2DR internalization, we additionally 
performed a receptor-ligand binding assay, in which the binding of [3H]spiperone, a tritium-
labeled D2DR antagonist, to membrane fractions of striatal extracts from wild-type and 
CIN85Δex2 knockout mice was analyzed. In agreement with the previous experiment, striatal 
neurons from CIN85Δex2 knockout mice displayed increased levels of cell surface-associated 
D2DRs after dopamine stimulation (Figure S7). Whereas wild-type neurons showed a 50% 
reduction of D2DR at the cell surface after 60 min of dopamine treatment, CIN85Δex2 
knockout neurons retained 80% of cell surface-associated D2DR. Taken together, these 
results strongly indicate that lack of CIN85-xl and CIN85-l leads to impaired D2DR 
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internalization, and in extension that CIN85 specifically regulates D2DR, but not D1DR, 
endocytosis in striatal neurons. Consistent with these findings, we found CIN85 and D2DRs 
co-clustered in punctuate, synapse-like structures in dendrites of primary striatal neurons 
(Figure 4D).  
 
CIN85Δex2 mice show altered behavioural responses to dopamine agonists and 
antagonists 
To investigate the connection between CIN85 and the D2DR under physiological conditions, 
we continued our studies by treating animals with the selective D2DR agonist quinpirole (or 
saline, as control). In both wild-type and CIN85Δex2 knockout mice repeated injections of 
quinpirole (0.5 mg/kg, s.c.) induced increased physical activity, manifested as an almost 2-
fold increase in distance travelled after 8 injections of quinpirole compared to saline-injected 
control animals of both genotypes (Figure 5A, left panel). Interestingly, wild-type animals 
increased their locomotor activity following quinpirole treatment to similar levels as 
CIN85Δex2 knockout mice under saline-treated conditions (Figure 5A, left panel). In light of 
previous reports this effect may be caused by a quinpirole-induced behavioural sensitisation 
and increased dopamine receptor density in the striatum of treated mice (Culver et al., 2008). 
To test this hypothesis we monitored the binding of [3H]spiperone to D2DRs in striatal 
extracts prepared from mice after the final treatment and completion of the locomotor activity 
recordings. Indeed, the [3H]spiperone binding was 36% higher in quinpirole-sensitized wild-
type mice compared to saline-injected controls (p<0.05). In CIN85Δex2 knockout mice, the 
[3H]spiperone binding was 45% and 73% higher in saline- and quinpirole-treated animals, 
respectively, when compared to wild-type mice treated with saline (p < 0.05) (Figure 5A, 
right panel). These data demonstrate that the D2DR levels in the striatum are increased in 
CIN85Δex2 knockout mice per se and that sensitization to the D2DR agonist quinpirole 
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increases the D2DR levels even further. In all cases, the level of striatal D2DR was thus 
strongly correlated with the intensity of the locomotor activity.   
To further address the physiological relevance of CIN85 in dopaminergic 
neurotransmission, we investigated the effect of quinpirole and haloperidol, a 
pharmacological inhibitor of dopamine receptors, on the behavior of CIN85Δex2 knockout 
mice. At low doses, haloperidol is a selective antagonist for D2 dopamine receptors, whereas 
higher doses have been reported to act more promiscuously and target also D1 dopamine 
receptors for inhibition (Leysen et al, 1988). Interestingly, we found that CIN85Δex2 animals 
were significantly less sensitive to low doses of quinpirole or haloperidol, compared to wild-
type littermates (Figures 5B and 5C). Whereas wild-type mice exposed to a threshold dose 
of quinpirole (0.01 mg/kg) showed increased (approximately 34%) locomotor activity as 
indicated by total distance travelled (Figure 5B), CIN85Δex2 mutants appeared to be 
unaffected (genotype x treatment interaction: F(1,7) = 4.17, p < 0.05). Correspondingly, wild-
type control animals displayed significantly reduced locomotor activity (approximately 40%) 
when treated with a low dose of haloperidol (0.05 mg/kg) (treatment effect: F(1,1) = 8.51, p < 
0.01, Bonferroni post-test vehicle vs. haloperidol for wild-type: t = 2.847, p < 0.05) while in 
contrast, CIN85Δex2 mutants did not (Bonferroni post-test vehicle vs. haloperidol for 
CIN85Δex2 mutants: t = 1.331, n.s.) (Figure 5C). Higher doses of haloperidol (0.25 and 0.5 
mg/kg) suppressed locomotor activity to a similar extent in both genotypes. In contrast, 
treatment of wild-type and CIN85Δex2 mutants with a low dose of the D1-selective dopamine 
receptor antagonist SCH23390 (0.03 mg/kg, Figure 5D) yielded comparable suppression of 
locomotor activity in both genotypes (treatment effect: F(1,1) = 16.89, p < 0.001, Bonferroni 
post-tests vehicle vs. SCH23390 for wild-type: t = 2.365, p < 0.05, and for CIN85Δex2 
mutants: t = 3.459, p < 0.01; genotype x treatment interaction: F(1,43) = 0.47, n.s.). 
Importantly, the effect produced by the chosen dose of the D1-ligand SCH23390 was in the 
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same range as that of the two D2-ligands, i.e. 0.03 mg/kg SCH23390 reduced locomotor 
activity in wild-type mice by 28% (Figure 5D). Taken together, these findings reinforce the 
notion that CIN85 plays a specific role in D2-mediated, but not in D1-mediated processes in 
vivo.  
 
Reduced complex formation between endophilins and D2 dopamine receptors in 
CIN85Δex2 knockout mice 
During receptor tyrosine kinase (RTK)-mediated endocytosis, CIN85 is targeted to activated 
receptors via the E3 ubiquitin ligase Cbl, where it functions to recruit components of the 
endocytic machinery that ultimately induces receptor internalization (Petrelli et al., 2002; 
Soubeyran et al., 2002). In order to investigate whether CIN85 has a similar role during 
D2DR endocytosis, we analyzed whether CIN85 is associated with endocytic protein 
complexes in synaptosome fractions prepared from mouse striata, focusing on endocytic 
adaptor proteins previously implicated either to interact with CIN85 or to play a role in 
dopamine receptor endocytosis. Similar to other cell surface receptors, we found that 
endogenous CIN85 co-immunoprecipitates with the D2DR receptor itself, as well as with the 
endocytic effector proteins endophilin and dynamin in samples from wild-type animals 
(Figure 5E). Interestingly, we also found CIN85 to associate with PSD-95, a prototypical 
scaffolding protein localized at post-synaptic densities, which has been shown to facilitate 
constitutive endocytosis of dopamine receptors (Figure 5E) (Zhang et al., 2007). As expected, 
neither of these interactions was observed in CIN85Δex2 knockout striata (Figure 5E). 
Knowing that CIN85 is associated with several endocytic regulators, we next 
examined how loss of CIN85 affects the complex formation between these components and 
D2 dopamine receptors. Again, we performed co-immunoprecipitation experiments in 
synaptosomal fractions from mouse striata. When concurrently analyzing wild-type and 
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CIN85Δex2 knockout preparations, it was clear that in the absence of CIN85, the complex 
formation of endophilin with D2DRs was strongly reduced, whereas the association of 
D2DRs with dynamin and PSD-95 was unaltered (Figure 5F, left panel). Quantification of 
the binding of endophilin to D2DRs in wild-type and CIN85Δex2 striatal synaptosome 
fractions from four independent experiments showed that the interaction between D2DR and 
endophilin in CIN85Δex2 knockout striata is significantly decreased to about 65% of the 
interaction observed in wild-type samples (Student’s t-test, p < 0.05) (Figure 5F, middle and 
right panels). We thus conclude that CIN85 plays a role in engaging endophilins in D2 
dopamine receptor complexes, thereby promoting receptor endocytosis. 
Finally, we attempted to uncover the mechanism by which CIN85 may be recruited to 
dopamine receptor complexes. We could not detect a direct binding between dopamine 
receptors and CIN85 in GST overlay assays (data not shown), suggesting that the interaction 
is likely to be mediated through an intermediate mechanism, possibly by recruitment via one 
or several of the many dopamine receptor interacting proteins (DRIPs) (Kabbani and 
Levenson, 2007; Yao et al., 2008). Whereas we were unable to detect an interaction between 
D2DRs and c-Cbl/Cbl-b (data not shown) we have found CIN85 to interact with p62 in GST 
pull-down and co-immunoprecipitation assays (Figure S8). This is highly interesting in light 
of a recent report describing p62 as a novel DRIP, specifically involved in the trafficking of 
D2 dopamine receptors (Kim et al., 2008).  
 
Discussion 
 
CIN85 regulates locomotor and exploratory behavior 
In this study we lay down an important piece of the puzzle regarding the regulation of 
dopamine receptor signaling circuits in the CNS. By conventional methods we have 
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generated mice deficient of CIN85 expression in the brain and thus concluded that loss of 
CIN85 gives rise to hyperactive phenotypes. In wild-type neurons CIN85 is enriched in 
dendritic spines and it clearly plays a crucial role in stabilizing endophilin binding to D2 
dopamine receptors in the striatum. In consequence, absence of CIN85 gives rise to 
insufficient endocytic internalization of D2 dopamine receptors after dopamine stimulation, 
causing increased striatal dopamine receptor levels, which can, at least in part, explain the 
enhanced locomotor and exploratory behavior we observe in the CIN85Δex2 mice. 
The involvement of dopaminergic signaling in the regulation of movement, emotion 
and reward feelings is well established (Arias-Carrion and Poppel, 2007). In agreement, 
aberrations in these pathways have been strongly linked to various neurological disorders, 
including Parkinson’s disease, schizophrenia, ADHD and Huntington’s disease (Arias-
Carrion and Poppel, 2007; Gainetdinov et al., 2004). The molecular defects underlying these 
pathologies have not been fully characterized, but may include alterations in the expression 
levels of dopamine ligands and/or receptors, as well as defects in downstream signaling 
events (Bellgrove and Mattingley, 2008; O'Connell et al., 2008). Interestingly, the 
hyperactive behavior evoked by alterations in other pathways (such as glutamatergic and 
serotonergic cascades) or by the action of chemical substances (such as haloperidol and 
clozapine), in many cases also indirectly affect dopaminergic signaling. Specifically, in 
several such cases, the described defect or compound has been reported to stimulate increased 
levels of high-affinity state D2 dopamine receptors (D2High) in the striatum and nucleus 
accumbens (Seeman et al., 2006).  
 
CIN85 regulates dopamine receptor endocytosis in the striatum 
This report provides the first study of a mammal where loss of CIN85 is analyzed in vivo. 
Specifically, we have generated mice in which the two CIN85 isoforms expressed in the CNS, 
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CIN85-xl and -l, have been removed. Most probably due to the presence of CD2AP, together 
with multiple alternative CIN85 isoforms expressed in other tissues, CIN85Δex2 mice are 
viable and fertile. This feature has thus enabled us to identify tissue-specific functions of 
CIN85 in the brain, in the regulation of proper neurotransmission.  
Under physiological conditions, endocytic internalization of dopamine receptors is a 
crucial means by which neurons, in response to dopamine stimulation, can adjust their 
excitability potential, by either degrading or recycling receptors back to the plasma 
membrane (von Zastrow, 2003). A stringent control of this dynamic trafficking of dopamine 
receptors, as well as receptors for other neurotransmitter substances, is essential to ensure 
accurate transmission of neuronal information and proper regulation of synaptic plasticity 
(Gainetdinov et al., 2004). We have discovered that CIN85 affects the endocytosis of D2, but 
not D1, dopamine receptors in primary striatal neurons. The resulting increase of surface-
associated D2 dopamine receptors in CIN85Δex2 knockout mouse striatal neurons and ensuing 
hyperactivity phenotype are in line with previous findings, showing that activation of post-
synaptic D2 dopamine receptors results in increased locomotor activity and that D2 dopamine 
receptor knockout mice display reduced spontaneous movement (Baik et al., 1995; Jackson 
and Westlind-Danielsson, 1994). Importantly, activation of D1 dopamine receptors, on the 
other hand, has little or no effect on locomotor activity (Jackson and Westlind-Danielsson, 
1994). The specificity of CIN85 involvement in D2 dopamine receptor endocytosis could 
have multiple explanations. Either it may be a result of the restricted expression of D1 and 
D2 dopamine receptors in distinct striatal neuron populations (Missale et al., 1998) causing a 
cell-specific positioning of CIN85 preferentially in D2DR-expressing neurons, or simply that 
CIN85 performs diverse functions during the internalization of different receptor types. 
Indeed, separate endocytic machineries and routes have been reported for D1 versus D2 
dopamine receptors (Iizuka et al., 2007; Kabbani and Levenson, 2007; Vickery and von 
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Zastrow, 1999). Interestingly, we find CIN85 co-clustered with D2DRs in synapse-like 
structures in primary striatal neurons. Taken together, our data imply a specific role for 
CIN85 in the regulation of D2 dopamine receptor endocytosis in striatal neurons. 
 
CIN85 facilitates complex formation between endophilins and D2 dopamine receptors 
Molecularly, we have observed that CIN85 displays important scaffolding functions in the 
complex formation between endophilins and D2 dopamine receptors in striatal neurons, a 
finding that is in agreement with previous discoveries showing a direct interaction between 
endophilins and CIN85 during the initiation of receptor internalization (Petrelli et al., 2002; 
Soubeyran et al., 2002). The endophilins constitute a family of proteins with well-established 
functions in the process of endocytosis, during which they are important both for the 
recruitment of endocytic machinery components to sites of activated receptors, as well as for 
the induction of membrane curvature, a function mediated via their N-BAR domains (Gallop 
et al., 2006; Masuda et al., 2006). Insufficient targeting of endophilins to dopamine receptor 
complexes could therefore result in accumulation of activated receptors at the plasma 
membrane of neurons, thereby enhancing dopaminergic signaling activities, and in extension 
cause aberrations in behavior.  
Importantly, this study provides the first evidence that CIN85/endophilin complexes 
are involved in the endocytosis of a member of the G protein-coupled receptor (GPCR) 
family. In light of this finding it is interesting to remark that the arrestins, another family of 
adaptor proteins with well-established functions in GPCR endocytosis and trafficking, also 
play a role in internalization of RTKs (Lefkowitz et al., 2006), thus exposing both CIN85 and 
arrestins as adaptors with the capacity to regulate the endocytosis and trafficking of a broad 
range of receptor types, including both RTKs and GPCRs. Despite extensive efforts, we have 
not been successful in clearly establishing the mechanism of CIN85 recruitment to dopamine 
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receptor complexes. The interaction is likely to be mediated through an intermediate 
mechanism, possibly by recruitment via one or several of the many dopamine receptor 
interacting proteins, such as p62 which we indeed have found in complex with CIN85 
(Kabbani and Levenson, 2007; Yao et al., 2008). The multiplicity of possible interacting 
partners and the redundancy between distinct key pathways could explain why the loss 
CIN85 function can have deleterious effects on a selection of receptor types in specific 
tissues, while other classes of receptors in contrast appear to be unaffected (Kobayashi et al., 
2004; Petrelli et al., 2002; Soubeyran et al., 2002). Indeed, a role of CIN85 specifically in the 
regulation of D2DR activity would be in agreement with the reported hypoactivity (i.e. 
reduced locomotor activity) displayed by D2DR knockout mice, which is in contrast to the 
hyperactivity which has been observed in mice deficient of other D2-like dopamine receptor 
subtypes (Holmes et al., 2004). 
 
Increased D2DR levels in the absence of CIN85 correlate with hyperactive behavior and 
altered metabolism 
During our extensive physiological examination of the CIN85Δex2 mice, we were interested to 
find that mice lacking striatal expression of CIN85 display a lean body composition, even 
though consuming more food than wild-type animals. However, in contrast to c-Cbl 
knockouts in which the anomalous lean body composition is accompanied by alterations in 
insulin metabolism, CIN85Δex2 mice did not show any significant improvements in 
conventional glucose tolerance tests (data not shown). The explanation for this phenotypical 
trait may instead be directly linked to the observed alterations in dopaminergic activity, given 
the previously reported involvement of D2DR-mediated signaling in the regulation of 
appetite, energy intake and obesity. Multiple studies have shown a correlation between 
striatal D2DR expression levels and body composition and have associated low D2DR with 
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obesity (Epstein et al., 2007). A recent report has furthermore demonstrated a strong link 
between certain D2DR allelic variations and obesity, suggesting that individuals with certain 
genotypes resulting in dopaminergic hypofunction are prone to obesity (Stice et al., 2008). 
Increased dopaminergic signaling is therefore in agreement with the slim appearance of 
CIN85Δex2 knockouts.  
 
Concluding remarks 
Notably, a role of CIN85 at neuronal synapses is well in line with the reported importance of 
CD2AP/CIN85 at immunological synapses in T cells, as well as in the slit diaphragm in 
kidney glomeruli, given the structural as well as functional similarities between neuronal 
synapses and these specialized cell surface contacts (Dustin and Colman, 2002; Shih et al., 
1999). In conclusion, CIN85 is a novel regulator of D2DR endocytosis in striatal neurons, 
involved in controlling locomotor and exploratory behavior in mice. 
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 Materials and Methods 
 
Generation of the CIN85Δex2 knockout mice 
The removal of exon 2 from the mouse CIN85 locus by homologous recombination and the 
generation of the CIN85Δex2 knockout mice are described in the Supplementary information.  
 
Phenotypic analyses of behavior, metabolism and other parameters  
See the Supplementary information. 
 
Immunofluorescence of primary neurons 
See the Supplementary information. 
 
Isolation of synaptosomes and post-synaptic density fractions 
 See the Supplementary information. 
 
Dopamine receptor biotinylation and endocytosis assay 
See the Supplementary information.  
 
Supplementary information 
Supplementary information includes eight figures and experimental details and is available at 
The EMBO Journal Online. 
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Figure legends  
 
Figure 1. CIN85 is highly expressed in neurons where it localizes to post-synaptic sites. 
(A) Western blot showing CIN85 expression in different mouse brain regions. Lysates (15 μg 
protein/lane) of the indicated brain regions from wild-type (+/+) and CIN85Δex2 knockout (-/-) 
mice were separated by 7% SDS-PAGE and immunoblotted with antibodies against CIN85 
(CT). Equal protein loading was confirmed by re-blotting with anti-β-actin antibodies.  
(B) In primary hippocampal neurons derived from wild-type rat, CIN85 (SETA antibody, 
green) is localized to dendritic spines, where it is accumulated in post-synaptic compartments, 
co-localizing with F-actin (red, upper panel) and PSD-95 (red, middle panel), closely 
juxtaposing the pre-synaptic synaptophysin protein (red, lower panel). Scale bars: 10 µm.  
(C) CIN85 (green) localizes to actin-positive (red), spine-like structures in dendrites of 
primary rat striatal neurons. Cells were fixed and stained with antibodies against CIN85 
(SETA antibody, green) and with rhodamine phalloidin (red). Scale bars: 10 µm.  
(D) CIN85 is present in post-synaptic compartments in mouse brains. Synaptosome (SNS) 
fractions were isolated using the Percoll-step gradient method from whole brain lysates as 
described in the Supplementary information. The Western blot shows that CIN85, PSD-95 
and synaptophysin are present in SNS fractions and that extraction with Triton X-100 
solubilizes pre-synaptic synaptophysin into supernatant 1 (S1), whereas CIN85 and PSD-95 
are present in post-synaptic fractions (pellet 2, P2, after a second Triton X-100 extraction). 
Supernatant 2 (S2) is the supernatant after the second Triton X-100 extraction. 
(E) CIN85 localizes to post-synaptic compartments in the striatum. Synaptosomes from 
mouse striata were prepared using a sucrose density gradient method as described in the 
Supplemental information and immunoblotted with antibodies against CIN85 and PSD-95. 
WSL, whole striatal lysates; SNS, synaptosomes; PSD-s, supernatant of PSD fraction; PSD-p, 
pellet of PSD fraction. Each lane contains 15 μg of total protein. 
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 Figure 2. Generation of CIN85Δex2 knockout mice.  
(A) Gene targeting of the CIN85 locus by removal of exon 2 by homologous recombination. 
The targeting vector consisted of a 6.0 kb 5’ homology region, the pGNA backbone 
containing LacZ and neomycin cassettes followed by a 3.0 kb 3’ homology region. The wild-
type and targeted loci with their respective restriction sites are indicated. The arrows (1, 2, 3, 
4) represent the primers used for genotyping of ES cells and CIN85Δex2 knockout mice (see 
Figure S3 for primer sequences). The 1.2 kb probe used for Southern blot detects an 8 kb 
product in wild-type mice and a 13 kb product in CIN85Δex2 knockout mice after HindIII 
digestion.  
(B) Confirmation of recombinant targeting events in ES cell clones by Southern blot. 
Genomic DNA from wild-type ES cells and targeted ES cell clones (D3 and D8) was 
digested with HindIII and analyzed by Southern blotting using the probe indicated in (A). 
The two targeted ES cell clones showed a 13 kb mutant band, indicating successful 
integration of the targeting vector by homologous recombination, whereas the wild-type ES 
cells, as expected, showed the 8 kb band of the wild-type locus (NC). An extended form of a 
linearized targeting vector was used as a positive control (PC).  
(C) Confirmation of the targeting event in CIN85Δex2 knockout mice by PCR, using a mixture 
of primers 1, 2 and 3. CIN85Δex2 knockout mice (-/-) give rise to the expected 1.5 kb product 
(primers 2 and 3), wild-type mice (+/+) the expected 0.5 kb product (primers 1 and 3) and 
heterozygous mice (+/-) to both products (primers 1, 2 and 3). Primer sequences are found in 
Figure S3A.  
(D) Whole tissue lysates from mouse brain, thymus and spleen (200 µg/lane) from wild-type 
(+/+) and CIN85Δex2 knockout mice (-/-) were subjected to immunoprecipitation with anti-
CIN85 (CT) antibodies. Subsequent Western blot analysis with antibodies against CIN85 
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confirms the removal of CIN85-xl and CIN85-l in the brain and of CIN85-l in thymus and 
spleen in CIN85Δex2 knockouts. CIN85-ΔA remains in thymus and spleen. Some smaller 
isoforms present in thymus and spleen are also removed in CIN85Δex2 knockouts. 
 
Figure 3. CIN85Δex2 knockout mice display metabolic and behavioral phenotypes.  
(A) CIN85Δex2 mutant mice display abnormal metabolic parameters. Both male (M) and 
female (F) CIN85Δex2 knockout mice (-/-) showed a leaner body mass, as well as a decrease in 
total and subcutaneous fat content as compared to their wild-type littermates (+/+). Female 
CIN85Δex2 mice also showed a significantly increased energy uptake compared to their wild-
type littermates (+/+). The graphs are based on the values in the table presented in Figure 
S4B. *, p < 0.05.  
(B) CIN85Δex2 knockout mice are hyperactive. Behavioral analysis of 8-10 week-old 
CIN85Δex2 (-/-) mice and wild-type (+/+) littermate controls (n = 22-26 per genotype) by the 
Modified Hole Board test (described in detail in the Supplemental information). The 
CIN85Δex2 knockout mice showed significantly increased forward locomotor activity, speed, 
turning frequency, board entry frequency and hole exploration frequency, as compared to 
wild-type controls; *, p < 0.05; **, p < 0.01, ***, p < 0.01,  +/+ vs. -/-.  
 
Figure 4. Impaired endocytic internalization of D2 dopamine receptors in mice lacking 
CIN85 expression in the CNS. 
 (A) The levels of dopamine (DA) and its metabolites (3,4-dihydroxyphenylacetic acid, 
DOPAC and homovanillic acid, HVA) are increased in the striatum of CIN85Δex2 knockout 
mice. The contents of total striatal dopamine, DOPAC and HVA were determined by high 
performance liquid chromatography using an electro-chemical (HPLC-EC) detector as 
described in the Supplementary information. Differences between wild-type (+/+) and 
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CIN85Δex2 knockout mice (-/-) were analyzed using a Student’s t-test, with the level of 
significance set at p < 0.05. +/+: n = 4; -/-: n = 4.  
(B) D2 dopamine receptor endocytosis is impaired in striatal neurons deficient of CIN85. 
Representative immunoblots (left panel) and quantification (right panel) showing the amount 
of surface D2 dopamine receptors (D2DR) in cultured striatal neurons after dopamine 
stimulation. Striatal neurons were treated with dopamine hydrochloride (3-hydroxytyramine, 
20 mM) for the indicated times prior to biotinylation. The remaining cell surface proteins 
were subsequently isolated with avidin and analyzed by Western blotting. The quantification 
of surface-bound D2DRs after dopamine stimulation is normalized to and depicted as the 
reduction of band intensity as compared to non-stimulated cells at the indicated times. 
Differences between wild type (+/+) and CIN85Δex2 knockout (-/-) were analyzed by ANOVA 
and Duncan multiple range test for posthoc between group comparisons, with the level of 
significance set at p < 0.05. Glutamate receptor-2 (GluR-2) was used as an internal control. 
+/+: n = 3; -/-: n = 3. 
(C) Endocytosis of D1 dopamine receptors (D1DR) is not affected by loss of CIN85. 
Representative immunoblots and quantification showing the amount of surface D1DR in 
cultured striatal neurons before and after dopamine stimulation. Striatal neurons were treated 
with dopamine hydrochloride (20 μM) for 1 h prior to biotinylation. The remaining cell 
surface proteins were subsequently isolated with avidin and analyzed by Western blotting. 
D1DRs of cultured striatal neurons from wild-type (+/+) and CIN85Δex2 knockout mice (-/-) 
were internalized 69±5.7% and 63±8.8%, respectively. Glutamate receptor-2 (GluR-2) was 
used as an internal control. +/+: n = 3; -/-: n = 3. 
(D) CIN85 co-clusters with D2 dopamine receptors (D2DRs) at punctuate synapse-like 
structures in primary rat striatal neurons. Cells were fixed and stained with antibodies against 
CIN85 (SETA antibody, green) and D2DRs (red). Scale bars: 5 μm.  
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 Figure 5. Defective complex formation between endophilins and D2 dopamine receptors 
in CIN85Δex2 knockouts.  
(A) Locomotor responses (left panel) and [3H]spiperone binding (right panel) of quinpirole-
treated mice. Mice of the indicated genotypes were repeatedly injected with quinpirole (0.5 
mg/kg, s.c.) or saline in 48 hour intervals until a total of eight injections were completed as 
described in the Supplementary information. Immediately after each injection, the locomotor 
activity was measured for 30 min using an actimeter. The left panel shows the distance 
travelled (m) during the last 5 min of the 30-min testing period. Data are presented as the 
mean ± SEM (n=3). The difference between saline-injected wild-types and the other 
genotypes/treatments were analyzed by ANOVA and Student’s t-test, with the level of 
significance set at p<0.05. Right panel: After the final measurement of locomotor activity, the 
membrane fraction of the striatum (12.5 μg/reaction) was prepared and incubated with 
[3H]spiperone. Concentrations of [3H]spiperone ranging from 10 pM to 500 pM were used, 
and nonspecific binding was determined in the presence of D-butaclamol. Data are presented 
as the mean ± SEM (n=3). The differences between saline-injected wild types and the other 
genotypes/treatments  were analyzed by ANOVA and Duncan multiple range test for posthoc 
between group comparisons, with the level of significance set at p<0.05.  
(B) Total distance travelled after a threshold dose of quinpirole. 19-26 week-old CIN85Δex2 (-
/-) and wild type (+/+) littermate control mice (n = 10-15 per genotype) were subjected to the 
Modified Hole Board test 30 min after quinpirole injection (0 or 0.01 mg/kg i.p.) as described 
in the Supplementary information.  
(C) Total distance travelled after a low dose of haloperidol. 14-36 week-old CIN85Δex2 (-/-) 
and wild-type (+/+) littermate control mice (n = 10-13 per genotype) were subjected to the 
Modified Hole Board test 30 min after haloperidol injection (0 or 0.05 mg/kg i.p.) as 
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described in the Supplementary information. * p < 0.05, vehicle vs. haloperidol, Bonferroni 
posttests.  
(D) Total distance travelled after a low dose SCH23390. 10-11 week-old CIN85Δex2 (-/-) and 
wild-type (+/+) littermate control mice (n = 10-12 per genotype) were subjected to the 
Modified Hole Board test 30 min after SCH23390 injection (0 or 0.03 mg/kg i.p.) as 
described in the Supplementary information. * p < 0.05, ** p < 0.01, vehicle vs. SCH23390, 
Bonferroni posttests. 
(E) Synaptosome fractions were prepared from wild-type and CIN85Δex2 knockout mouse 
striata by sucrose density gradient centrifugation. 25 μg of fractionated protein was analyzed 
by immunoprecipitation (IP) followed by Western blotting (WB) using the indicated 
antibodies. CIN85 co-immunoprecipitates with D2DRs, the endocytic proteins endophilin 
and dynamin, as well as the post-synaptic density protein PSD-95, in wild-type, but not in 
CIN85Δex2 knockout samples. The upper band evident in the dynamin IP may be CIN85-xl. 
(F) The level of endophilin in complex with the D2DR is decreased in the striatal 
synaptosome fractions in CIN85Δex2 knockout mice. Synaptosomes of wild-type (+/+) and 
CIN85Δex2 knockout (-/-) mouse striata were prepared as in (E) and subjected to IP with anti-
D2DR antibodies and subsequent immunoblot analysis with antibodies against endophilin, 
dynamin, PSD-95 and the D2DR (left and middle panels). Western blots from four 
independent experiments are shown in the middle panel. Relative intensities of the endophilin 
levels in CIN85Δex2 knock-outs compared to wild-type for each of the four experiments are 
indicated. A graph depicting the mean value of the relative endophilin intensities in 
CIN85Δex2 knockout (-/-) compared to wild-type (+/+) mice from the four experiments is 
shown in the right panel. The value is presented as mean +/- SE. Differences between wild-
type (+/+) and CIN85Δex2 knockout mice (-/-) were analyzed using a Student’s t-test, with the 
level of significance set at p < 0.05. +/+: n = 4; -/-: n = 4. 
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